Update on pharmacotherapy guidelines for the treatment of neuropathic pain

Current Pain and Headache Reports

Volumn 10, Issue 3, 2006, Pages 185-190

  Dobecki, Douglas A ^b   Schocket, Sanford M ^b   Wallace, Mark S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CIMETIDINE; CITALOPRAM; CLOMIPRAMINE; CYTOCHROME P450 2D6; DESIPRAMINE; DIAZEPAM; DULOXETINE; FENTANYL; FLUOXETINE; GABAPENTIN; IMIPRAMINE; LIDOCAINE; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NORTRIPTYLINE; OPIATE DERIVATIVE; OXYCODONE; PAROXETINE; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ANALGESIA; ANTICONVULSANT ACTIVITY; APPETITE DISORDER; ARTICLE; ASTHENIA; BLURRED VISION; CLINICAL TRIAL; COGNITIVE DEFECT; CONCENTRATION LOSS; CONFUSION; CONSTIPATION; DELIRIUM; DIABETIC NEUROPATHY; DIARRHEA; DIZZINESS; DRUG ABSORPTION; DRUG ABUSE; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG OVERDOSE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERHIDROSIS; MAXIMUM PERMISSIBLE DOSE; META ANALYSIS; NAUSEA; NEUROPATHIC PAIN; NEUROTOXICITY; ORTHOSTATIC HYPOTENSION; PERIPHERAL EDEMA; PRACTICE GUIDELINE; QT PROLONGATION; SEDATION; SEIZURE; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; SUICIDE ATTEMPT; SWEATING; SYSTEMATIC REVIEW; TRANQUILIZING ACTIVITY; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA;

CENTRAL NERVOUS SYSTEM AGENTS; HUMANS; NEURALGIA; PRACTICE GUIDELINES AS TOPIC;

EID: 33745292743     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-006-0044-9     Document Type: Article

References (38)

1. Bennett GJ: Neuropathic pain: new insights, new interventions. Hosp Pract 1998, 33:95-98, 101-104, 107-110.
2. Dworkin RH, Backonja M, Rowbotham MC, et al.: Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003, 60:1524-1534.
3. Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999, 83:389-400.
4. O'Connor AB, Dworkin RH: Chronic neuropathic pain and advances in its treatment. Prog in Neuropathic Pain 2005, 19-30.
5. Package insert. L.p.C.C.p., Data on file. New York: Pfizer, Inc; 2005.
6. Randinitis EJ, Posvar EL, Alvey CW, et al.: Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol 2003, 43:277-283.
7. Dworkin RH, Corbin AE, Young JP Jr, et al.: Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003, 60:1274-1288.
8. Sabatowski R, Galvez R, Cherry DA, et al.: Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004, 109:26-35.
9. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U, et al.: Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004, 110:628-638.
10. Lesser H, Sharma U, LaMoreaux L, Poole RM, et al.: Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized, controlled trial. Neurology 2004, 63:2104-2110.
11. Field MJ, Hughes J, Singh L: Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 2000, 131:282-286.
12. Backonja M, Beydoun A, Edwards KR, et al.: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998, 280:1831-1836.
13. Rice AS, Maton S: Gabapentin in postherpetic neuralgia: a randomized, double-blind, placebo-controlled study. Pain 2001, 94:215-224.
14. Rowbotham M, Harden N, Stacey B, et al.: Gabapentin for the treatment of postherpetic neuralgia: a randomized, controlled trial. JAMA 1998, 280:1837-1842.
15. Max MB, Culnane M, Schafer SC, et al.: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987, 37:589-596.
16. Max MB, Kishore-Kumar R, et al.: Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991, 45:3-9.
17. Kishore-Kumar R, Max MB, et al.: Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990, 47:305-312.
18. Sindrup SH, Gram LF, Brosen K, et al.: The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990, 42:135-144.
19. Sindrup SH, Bjerre U, Dejgaard A, et al.: The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992, 52:547-552.
20. Wernicke J, Lu Y, D'Souza DN, et al.: Duloxetine at doses of 60 mg QD and 60 mg BID is effective in treatment of diabetic neuropathic pain (DNP). J Pain 2004, 5 (suppl):48.
21. Fava M, Mallinckrodt CH, Detke MJ, et al.: The effect of duloxetine on the painful physical symptoms in depressed patients: Do improvements in these symptoms result in higher remission rates? J Clin Psychiatry 2004, 65:521-530.
22. Rowbotham MC, Goli V, Kunz NR, Lei D: Venlafaxine extended-release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004, 110:697-706.
23. Tasmuth T, Hartel B, Kalso E: Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain 2002, 6:17-24.
24. Sindrup SH, Bach FW, Madsen C, et al.: Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003, 60:1284-1289.
25. Rowbotham MC, Davies PS, Verkempinck C, Galer BS, et al.: Lidocaine patch: double-blind, controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996, 65:39-44.
26. Rowbotham MC, Perander J, Friedman E: Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999, 80:533-538.
27. Galer BS, Jensen MP, Ma T, et al.: The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 2002, 18:297-301.
28. Meier T, Wasner G, Faust M, et al.: Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003, 106:151-158.
29. Harati Y, Gooch C, Swenson M, et al.: Double-blind, randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998, 50:1842-1846.
30. Sindrup SH, Andersen G, Madsen C: Tramadol relieves pain and allodynia in polyneuropathy: a randomized, double-blind, controlled trial. Pain 1999, 83:85-90.
31. Boureau F, Leallicier P, Kabir-Ahmadi M: Tramadol in postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 2003, 104:323-331.
32. Harati Y, Gooch C, Swenson M, et al.: Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications 2000, 14:65-70.
33. Raja SN, Haythornthwaite JA, Pappagallo M, et al.: Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002, 59:1015-1021.
34. Dellemijn PL, Vanneste JA: Randomised, double-blind, active placebo-controlled, crossover trial of intravenous fentanyl in neuropathic pain. Lancet 1997, 349:753-758.
35. Rowbotham M, Reisner-Keller L, Fields H: Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991, 41:1024-1028.
36. Watson CP, Babul N: Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998, 50:1837-41.
37. Huse E, Larbig W, Flor H, Birbaumer N: The effect of opioids on phantom limb pain and cortical reorganization. Pain 2001, 90:47-55.
38. Adriaensen H, Vissers K, Noorduin H, Meert T. Opioid tolerance and dependence: An inevitable consequence of chronic treatment? Acta Anaesthesiol 2003, 54:37-47.